Literature DB >> 27816525

Enhanced nucleoplasmic Ca2+ signaling in ventricular myocytes from young hypertensive rats.

Jelena Plačkić1, Sebastian Preissl2, Yulia Nikonova1, Florentina Pluteanu1, Lutz Hein3, Jens Kockskämper4.   

Abstract

Arterial hypertension causes left ventricular (LV) myocyte hypertrophy. Alterations in nuclear Ca2+ may be involved in regulation of histone acetylation, transcription and hypertrophy. Regulation of nuclear Ca2+ in hypertension, however, is unknown. Therefore, we elucidated cellular mechanisms underlying nuclear Ca2+ regulation in LV myocytes from hypertensive versus normotensive rats and evaluated possible consequences for Ca2+-dependent regulation of histone acetylation. LV myocytes and myocyte nuclei were isolated from young spontaneously hypertensive rats (SHR) shortly after development of hypertension. Normotensive Wistar-Kyoto rats (WKY) served as controls. Cytoplasmic and nucleoplasmic Ca2+ transients (CaTs) were imaged simultaneously using linescan confocal microscopy and Fluo-4. LV myocytes and nuclei from SHR exhibited hypertrophy. Cytoplasmic and nucleoplasmic CaTs were increased in SHR. The increase in nucleoplasmic Ca2+, however, exceeded the increase in cytoplasmic Ca2+, indicating enhanced nuclear Ca2+ signaling in SHR. Ca2+ load of sarcoplasmic reticulum and perinuclear Ca2+ stores was also increased in SHR, while fractional release from both stores remained unchanged. Intranuclear Ca2+ propagation was accelerated in SHR, associated with preserved density of nuclear envelope invaginations and elevated nuclear expression of nucleoporins and SR-Ca2+-ATPase, SERCA2a. Nuclear Ca2+/calmodulin-dependent protein kinase II delta (CaMKIIδ) expression was elevated and histone deacetylases exhibited redistribution from nucleus to cytosol associated with increased histone acetylation in SHR. Thus, in early hypertension, there is remodeling of nuclear Ca2+ handling resulting in enhanced nuclear Ca2+ signaling. Enhanced nuclear Ca2+ signaling, in turn, increases nuclear localization and activity of CaMKIIδ driving nuclear export of histone deacetylases and increased histone acetylation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium; Histone acetylation; Hypertension; Hypertrophy; Nucleus

Mesh:

Substances:

Year:  2016        PMID: 27816525     DOI: 10.1016/j.yjmcc.2016.11.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Phospholamban regulates nuclear Ca2+ stores and inositol 1,4,5-trisphosphate mediated nuclear Ca2+ cycling in cardiomyocytes.

Authors:  Mu Chen; Dongzhu Xu; Adonis Z Wu; Evangelia Kranias; Shien-Fong Lin; Peng-Sheng Chen; Zhenhui Chen
Journal:  J Mol Cell Cardiol       Date:  2018-09-24       Impact factor: 5.000

2.  Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy.

Authors:  Ketaki N Mhatre; Paulina Wakula; Oliver Klein; Egbert Bisping; Jakob Völkl; Burkert Pieske; Frank R Heinzel
Journal:  Cell Mol Life Sci       Date:  2018-07-30       Impact factor: 9.261

Review 3.  Calcium Signaling in Cardiomyocyte Function.

Authors:  Guillaume Gilbert; Kateryna Demydenko; Eef Dries; Rosa Doñate Puertas; Xin Jin; Karin Sipido; H Llewelyn Roderick
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

Review 4.  Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy.

Authors:  Carolina Jaquenod De Giusti; Julieta Palomeque; Alicia Mattiazzi
Journal:  Pflugers Arch       Date:  2022-01-03       Impact factor: 3.657

Review 5.  Inositol 1,4,5-trisphosphate receptors in cardiomyocyte physiology and disease.

Authors:  Kateryna Demydenko; Samaneh Ekhteraei-Tousi; H Llewelyn Roderick
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-10-03       Impact factor: 6.671

Review 6.  Four Dimensions of the Cardiac Myocyte Epigenome: from Fetal to Adult Heart.

Authors:  Carolin Rommel; Lutz Hein
Journal:  Curr Cardiol Rep       Date:  2020-03-19       Impact factor: 2.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.